Amneal

Amneal gets approval for generic version of Ortho Evra

Amneal gets approval for generic version of Ortho Evra

BRIDGEWATER, N.J.— Amneal Pharmaceuticals  has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for 150 mcg/day norelgestromin and 35 mcg/day ethinyl estradiol transdermal system. In conjunction with its approval, Amneal received a Competitive Generic Therapy (CGT) designation by the FDA and has been granted 180 days of exclusivity.

Amneal ships generic of Voltaren Gel

Amneal ships generic of Voltaren Gel

BRIDGEWATER, N.J. — Amneal Pharmaceuticals LLC has launched diclofenac sodium topical gel 1%, a pain reliever for osteoarthritis, in the United States. Amneal said its product, available in a 100-gram tube, is a first-to-market generic version of Voltaren Gel from Endo International plc and has begun shipping through wholesalers and directly to the trade. “We are